The latest announcement is out from Peijia Medical Ltd. ( (HK:9996) ).
Peijia Medical Limited announced the successful completion of the first patient treatment using its ReachTactile™ robotic-assisted TAVR system. This system, which was used in a clinical trial at Xiamen Cardiovascular Hospital, offers a cost-effective and innovative solution for TAVR therapy. It features a modular design that fits conventional catheter rooms, allows for precise operation, and reduces radiation exposure for cardiologists. The system’s remote control capabilities also enable long-distance operations and training, potentially impacting the company’s market position by offering advanced medical solutions.
More about Peijia Medical Ltd.
Peijia Medical Limited is a company incorporated in the Cayman Islands, focusing on the development of innovative medical devices. The company operates in the healthcare industry, specializing in robotic-assisted systems for transcatheter aortic valve replacement (TAVR) procedures.
YTD Price Performance: 17.71%
Technical Sentiment Signal: Buy
Current Market Cap: €399.6M
See more data about 9996 stock on TipRanks’ Stock Analysis page.